Search results
Heart Failure in Women: Key Differences and Clinical Tips
Medscape· 4 days agoCurrently, there are 6.7 million Americans with heart failure, and approximately 45% of them are...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 7 days agoThe drugmaker is also evaluating tirzepatide (the drug marketed under the brand names Mounjaro and...
2024 HFMC CME Symposium - Managing Worsening Heart Failure with Reduced Ejection Fraction:...
Digital Journal· 5 days agoJun. 13, 2024 / PRZen / HAZLET, N.J. -- In this educational initiative, the current definition and clinical impact of WHF will be described, and principles of management explained. A panel discussion ...
Daughter of the legendary James Brown battles heart failure
San Francisco Chronicle· 7 days agoDeanna Brown-Thomas was at her desk at the James Brown Family Foundation in Augusta, Georgia, when...
Delays After Tests for Suspected Heart Failure 'a Scandal'
Medscape· 1 day agoFew people with suspected heart failure and elevated N-terminal prohormone of brain natriuretic...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 5 days agoFurther regulatory submissions and market evaluations are underway to determine additional rollout...
Seven EMS Practices Boost Cardiac Arrest Survival Rates
Medscape· 6 days agoA study showed that seven practices by emergency medical services were linked to higher rates of...
NCH piloting the use of smart stethoscopes
WINK TV Southwest Florida· 4 days agoNow, thanks to artificial intelligence, the stethoscope just got a whole lot smarter. Today, the tried-and-true stethoscope is turning into a handheld...
Tenax Therapeutics, Inc. (NASDAQ:TENX) Short Interest Down 34.7% in May
ETF DAILY NEWS· 5 days agoTenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling ...
Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure,...
Digital Journal· 6 days agoRenova is exploring new therapeutic opportunities that have the potential to expand the use of Renova's gene therapy platform to include several pathologies associated with diabetes and heart ...